MGMT and central nervous system cancer: The ongoing debate among neuropathologists about whether or not MGMT testing should be incorporated into the next revision of the WHO classification scheme for central nervous system tumours also points at an emerging diagnostic role for MGMT. Meanwhile, an internationally accepted consensus as to the most appropriate diagnostic instrument for MGMT testing is still unmet [22].